The purpose of this release is to inform the readers that Lefland & Deplas has launched bladder cancer screening.
(1888PressRelease) October 13, 2012 - The multi-specialty health care practice Lefland & Deplas has announced the launch of its bladder cancer screening service. It is the first time any type of bladder cancer screening has been included in the practice's extensive list of internal medicine procedures.
Although the introduction of this service signifies Lefland & Deplas' entry into this field, the Long Island operation already offers a diverse array of services, such as cardiological, gastroenterological, preventive medicine and aesthetic procedures.
The procedure is non-invasive and typically only requires a urine sample from the patient requesting the screening. This allows the patient to have peace of mind knowing that process is pain free.
Other diagnostic tests made available by Lefland & Deplas include colon cancer screening, cardiopulmonary stress testing, Holter monitoring, prostrate cancer screening for men, bone density testing for women, mammograms, neurological testing, sleep apnea screening, EKG and lactose tolerance testing. The practice is an ICAEL certified cardiac stress testing lab.
Lefland & Deplas was founded by Renee R. Lefland, M.D. and Peter Deplas, M.D. and is affiliated with Winthrop University Hospital, North Shore/LIJ University Hospital and Mount Sinai Hospital, all in New York State. The internal medicine specialist has 2 locations in Garden City, both on Stewart Avenue. Including Drs. Lefland and Deplas, the practice has 6 board certified physicians in total.
About the Company:
Renee R. Lefland, MD and Peter Deplas, MD is a multi-specialty practice of board certified physicians located in Garden City, Long Island NY. It has been serving the community for over 20 years, providing first class care in a warm, caring, friendly environment.